LTA and synovial sarcoma: Furthermore, given this tight pathophysiological correlation observed, we hypothesize that a potential novel therapeutical approach targeting the LT pathway (for example, testing CysLT receptor antagonists) could be of benefit and should be explored in the management of SS patients.